Anti-BAP31/BCAP31 Antibody Picoband®

E.coli-derived human BAP31/BCAP31 recombinant protein (Position: M1-D242) . Human BAP31/BCAP31 shares 91.2% amino acid (aa) sequence identity with mouse BAP31/BCAP31.

1. Adachi, T., Schamel, W. W. A., Kim, K.-M., Watanabe, T., Becker, B., Nielsen, P. J., Reth, M. The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence. EMBO J. 15: 1534-1541, 1996. 2. Cacciagli, P., Sutera-Sardo, J., Borges-Correia, A., Roux, J.-C., Dorboz, I., Desvignes, J.-P., Badens, C., Delepine, M., Lathrop, M., Cau, P., Levy, N., Girard, N., Sarda, P., Boespflug-Tanguy, O., Villard, L. Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus. Am. J. Hum. Genet. 93: 579-586, 2013. 3. Lambert, G., Becker, B., Schreiber, R., Boucherot, A., Reth, M., Kunzelmann, K. Control of cystic fibrosis transmembrane conductance regulator expression by BAP31. J. Biol. Chem. 276: 20340-20345, 2001.

At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.